BIT Names CEO of Newly Established BIT Japan Ltd.

Share Article

BIT Analytical Instruments has named Mr. Hiroshi Mitsumaki as CEO of the company’s newly established BIT Japan Ltd.

BIT Analytical Instruments ( has officially announced Mr. Hiroshi Mitsumaki as CEO of BIT Japan, Ltd., located in Tokyo, Japan. The new company represents BIT’s market entry into Japan as BIT responds to the growing IVD market in Japan and developing Asian countries. Working in conjunction with BIT’s existing Chinese manufacturing base, BIT Japan Ltd. is expected to expand the sales and marketing activities of its contract development and manufacturing services for Japanese and other Asian clients in the IVD and life science fields.

Mr. Mitsumaki has more than 30 years of IVD system development and management experience and has served as president and CEO of the personal healthcare venture company at Hitachi, Ltd. In addition, Mr. Mitsumaki is experienced in large-scale project management with companies including Boehringer-Mannheim (currently Roche Diagnostics)/Hitachi 911 and MODULAR ANALYTICS system. Mr. Mitsumaki can be reached at Tel: +81-3-6717-2870 or Hiroshi.Mitsumak(at)@BIT-Instruments(dot)com.

Joining Mr. Mitsumaki in heading up the new venture will be Mr. Hayanami Kudo.
Mr. Kudo has more than 30 years of IVD service provider and management experience; most recently, he served as the executive vice president at SRL, Inc., the largest commercial laboratory in Japan.

The Asian IVD market has become the third largest region in the world, following the North American and European markets, and is viewed as a burgeoning business climate for high-tech IVD companies. Presently, there are few companies that can provide globally-competitive contract manufacturing services as well as product development and after-sales services to their IVD clients. BIT Companies have already accumulated experiences and proven capabilities in providing optimized, state-of-the-art product development and the latest manufacturing technologies in compliance with internationally relevant regulatory standards. BIT Japan will act as a bridge-head of BIT Companies in Asia to deliver “Instrumentation for Life” and to enable Japanese and Asian clients to launch their instruments faster and more cost-effectively than their competitors with full product support for the long term.

For more than 35 years, BIT Companies ( ) has provided instrument contract product development, manufacturing and after-sale services to medical, diagnostic, and bio-technology clients. As part of the financially-strong Messer Group, BIT Companies offer their systems solutions worldwide and with adherence to ISO13485 and 9001 standards. As a FDA registered contract service provider, BIT Companies meets the high standard of medical product regulation, meeting design-to-cost and time-to-market targets.

BIT Companies include Source Scientific, LLC in Irvine, CA, USA (, BIT Analytical Instruments, Inc. in Ludlow, MA, USA , BIT Analytical Instruments GmbH in Schwalbach, Germany, BIT CNC Machining in Kunshan, China and BIT Japan, Ltd in Tokyo.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brian Jarvis
Visit website